140 related articles for article (PubMed ID: 36982886)
21. Benzoxazole derivatives as new generation of anti-breast cancer agents.
Omar AME; AboulWafa OM; El-Shoukrofy MS; Amr ME
Bioorg Chem; 2020 Mar; 96():103593. PubMed ID: 32004897
[TBL] [Abstract][Full Text] [Related]
22. Effect of costunolide and dehydrocostus lactone on cell cycle, apoptosis, and ABC transporter expression in human soft tissue sarcoma cells.
Kretschmer N; Rinner B; Stuendl N; Kaltenegger H; Wolf E; Kunert O; Boechzelt H; Leithner A; Bauer R; Lohberger B
Planta Med; 2012 Nov; 78(16):1749-56. PubMed ID: 23047249
[TBL] [Abstract][Full Text] [Related]
23. Incorporation of Sulfonamide Moiety into Biguanide Scaffold Results in Apoptosis Induction and Cell Cycle Arrest in MCF-7 Breast Cancer Cells.
Markowicz-Piasecka M; Sadowski K; Huttunen J; Sikora J; Huttunen KM
Int J Mol Sci; 2021 May; 22(11):. PubMed ID: 34073245
[TBL] [Abstract][Full Text] [Related]
24. Transcriptional targeting of human liver carboxylesterase (hCE1m6) and simultaneous expression of anti-BCRP shRNA enhances sensitivity of breast cancer cells to CPT-11.
Mishra MN; Vangara KK; Palakurthi S
Anticancer Res; 2014 Nov; 34(11):6345-51. PubMed ID: 25368234
[TBL] [Abstract][Full Text] [Related]
25. Debio-0932, a second generation oral Hsp90 inhibitor, induces apoptosis in MCF-7 and MDA-MB-231 cell lines.
Özgür A; Kara A; Gökşen Tosun N; Tekin Ş; Gökçe İ
Mol Biol Rep; 2021 Apr; 48(4):3439-3449. PubMed ID: 33999319
[TBL] [Abstract][Full Text] [Related]
26. Drug efflux by breast cancer resistance protein is a mechanism of resistance to the benzimidazole insulin-like growth factor receptor/insulin receptor inhibitor, BMS-536924.
Hou X; Huang F; Carboni JM; Flatten K; Asmann YW; Ten Eyck C; Nakanishi T; Tibodeau JD; Ross DD; Gottardis MM; Erlichman C; Kaufmann SH; Haluska P
Mol Cancer Ther; 2011 Jan; 10(1):117-25. PubMed ID: 21220496
[TBL] [Abstract][Full Text] [Related]
27. Lipotropes enhance the anti-proliferative effect of chemotherapeutic drugs in MCF-7 human breast cancer cells.
Cho K; Mabasa L; Walters MW; Park CS
Oncol Rep; 2013 Jun; 29(6):2237-42. PubMed ID: 23588242
[TBL] [Abstract][Full Text] [Related]
28. Modulation of function of three ABC drug transporters, P-glycoprotein (ABCB1), mitoxantrone resistance protein (ABCG2) and multidrug resistance protein 1 (ABCC1) by tetrahydrocurcumin, a major metabolite of curcumin.
Limtrakul P; Chearwae W; Shukla S; Phisalphong C; Ambudkar SV
Mol Cell Biochem; 2007 Feb; 296(1-2):85-95. PubMed ID: 16960658
[TBL] [Abstract][Full Text] [Related]
29. Epithelial cell adhesion molecule promotes breast cancer resistance protein-mediated multidrug resistance in breast cancer by inducing partial epithelial-mesenchymal transition.
Shi RZ; He YF; Wen J; Niu YN; Gao Y; Liu LH; Zhang XP; Wang Y; Zhang XL; Zhang HF; Chen M; Hu XL
Cell Biol Int; 2021 Aug; 45(8):1644-1653. PubMed ID: 33760350
[TBL] [Abstract][Full Text] [Related]
30. 11a-N-Tosyl-5-deoxi-pterocarpan, LQB-223, a novel compound with potent antineoplastic activity toward breast cancer cells with different phenotypes.
Lemos LG; Nestal de Moraes G; Delbue D; Vasconcelos Fda C; Bernardo PS; Lam EW; Buarque CD; Costa PR; Maia RC
J Cancer Res Clin Oncol; 2016 Oct; 142(10):2119-30. PubMed ID: 27520309
[TBL] [Abstract][Full Text] [Related]
31. Novel thiosemicarbazides induced apoptosis in human MCF-7 breast cancer cells via JNK signaling.
Malki A; Elbayaa RY; Ashour HM; Loffredo CA; Youssef AM
J Enzyme Inhib Med Chem; 2015; 30(5):786-95. PubMed ID: 25363687
[TBL] [Abstract][Full Text] [Related]
32. Oxocrebanine: A Novel Dual Topoisomerase inhibitor, Suppressed the Proliferation of Breast Cancer Cells MCF-7 by Inducing DNA Damage and Mitotic Arrest.
Yu L; Han S; Lang L; Song H; Zhang C; Dong L; Jia S; Zhang Y; Xiao D; Liu J; Xu Y; Zhang X
Phytomedicine; 2021 Apr; 84():153504. PubMed ID: 33611211
[TBL] [Abstract][Full Text] [Related]
33. Sulfonamide metformin derivatives induce mitochondrial-associated apoptosis and cell cycle arrest in breast cancer cells.
Markowicz-Piasecka M; Huttunen J; Zajda A; Sikora J; Huttunen KM
Chem Biol Interact; 2022 Jan; 352():109795. PubMed ID: 34953865
[TBL] [Abstract][Full Text] [Related]
34. Paeonol reverses paclitaxel resistance in human breast cancer cells by regulating the expression of transgelin 2.
Cai J; Chen S; Zhang W; Hu S; Lu J; Xing J; Dong Y
Phytomedicine; 2014 Jun; 21(7):984-91. PubMed ID: 24680370
[TBL] [Abstract][Full Text] [Related]
35. VALD-3, a Schiff base ligand synthesized from o-vanillin derivatives, induces cell cycle arrest and apoptosis in breast cancer cells by inhibiting the Wnt/β-catenin pathway.
Li H; Dang C; Tai X; Xue L; Meng Y; Ma S; Zhang J
Sci Rep; 2021 Jul; 11(1):14985. PubMed ID: 34294779
[TBL] [Abstract][Full Text] [Related]
36. A Promising Microtubule Inhibitor Deoxypodophyllotoxin Exhibits Better Efficacy to Multidrug-Resistant Breast Cancer than Paclitaxel via Avoiding Efflux Transport.
Zang X; Wang G; Cai Q; Zheng X; Zhang J; Chen Q; Wu B; Zhu X; Hao H; Zhou F
Drug Metab Dispos; 2018 May; 46(5):542-551. PubMed ID: 29523600
[TBL] [Abstract][Full Text] [Related]
37. The short-chain fatty acid butyrate is a substrate of breast cancer resistance protein.
Gonçalves P; Gregório I; Martel F
Am J Physiol Cell Physiol; 2011 Nov; 301(5):C984-94. PubMed ID: 21775706
[TBL] [Abstract][Full Text] [Related]
38. Novel microtubule-targeting agents, pyrrolo-1,5-benzoxazepines, induce apoptosis in multi-drug-resistant cancer cells.
Nathwani SM; Butler S; Fayne D; McGovern NN; Sarkadi B; Meegan MJ; Lloyd DG; Campiani G; Lawler M; Williams DC; Zisterer DM
Cancer Chemother Pharmacol; 2010 Aug; 66(3):585-96. PubMed ID: 20020128
[TBL] [Abstract][Full Text] [Related]
39. Folate deprivation results in the loss of breast cancer resistance protein (BCRP/ABCG2) expression. A role for BCRP in cellular folate homeostasis.
Ifergan I; Shafran A; Jansen G; Hooijberg JH; Scheffer GL; Assaraf YG
J Biol Chem; 2004 Jun; 279(24):25527-34. PubMed ID: 15047700
[TBL] [Abstract][Full Text] [Related]
40. Glucosamine attenuates drug resistance in Mitoxantrone-resistance breast cancer cells.
Valinezhad Sani F; Palizban A; Mosaffa F; Jamialahmadi K
J Pharm Pharmacol; 2021 Jun; 73(7):922-927. PubMed ID: 33885909
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
